Frontiers in Immunology · 2019 · 72 citations · 44 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoantigensAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesAutoimmune InflammationAutoimmune VasculitisAnti-myeloperoxidase AntibodiesAnti-neutrophil Cytoplasmic AntibodiesAutoimmune Vasculitis PathologyGranulocyte ResponsesImmune-mediated VasculitisVasculitic InflammationVasculitis Pathogenesis
Low Density Granulocytes (LDGs), which appear in the peripheral blood mononuclear cell layer of density-separated blood, are seen in cancer, sepsis, autoimmunity, and pregnancy. Their significance in ANCA vasculitis (AAV) is little understood. As these cells bear the autoantigens associated with this condition and have been found to undergo spontaneous NETosis in other diseases, we hypothesized that they were key drivers of vascular inflammation. We found that LDGs comprise a 3-fold higher fraction of total granulocytes in active vs. remission AAV and disease controls. They are heterogeneous, split between cells displaying mature (75%), and immature (25%) phenotypes. Surprisingly, LDGs (unlike normal density granulocytes) are hyporesponsive to anti-myeloperoxidase antibody stimulation, despite expressing myeloperoxidase on their surface. They are characterized by reduced CD16, CD88, and CD10 expression, higher LOX-1 expression and immature nuclear morphology. Reduced CD16 expression is like that observed in the LDG population in umbilical cord blood and in granulocytes of humanized mice treated with G-CSF. LDGs in AAV are thus a mixed population of mature and immature neutrophils. Their poor response to anti-MPO stimulation suggests that, rather than being a primary driver of AAV pathogenesis, LDGs display characteristics consistent with generic emergency granulopoiesis responders in the context of acute inflammation.
44
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Zvi G. Fridlender, Jing Sun, Samuel Kim et al. · Cancer Cell · 2009 · 3.3K citations · Full text
Medicine, Immunology, Oncology +12
Ronald J. Falk, J. Charles Jennette · New England Journal of Medicine · 1988 · 1.4K citations
Medicine, Immunology, Pathology +17
Eneida C. Villanueva, Srilakshmi Yalavarthi, Céline C. Berthier et al. · The Journal of Immunology · 2011 · 1.2K citations · Full text
Life Sciences, Immunology, Pathology +17